https://scholars.lib.ntu.edu.tw/handle/123456789/557501
標題: | Detection of YMDD mutation using mutant-specific primers in chronic hepatitis B patients before and after lamivudine treatment | 作者: | Lee, Cha-Ze Lee, Hsuan-Shu GUAN-TARN HUANG PEI-MING YANG JIN-CHUAN SHEU |
公開日期: | 2006 | 出版社: | Baishideng Publishing Group Co | 卷: | 12 | 期: | 33 | 起(迄)頁: | 5301-5305 | 來源出版物: | World Journal of Gastroenterology | 摘要: | Aim: To develop a PCR assay using mutant-specific primers to detect mutation of tyrosine-methionine-aspartate-aspartate (YMDD) motif of HBV to tyrosine-valine-aspartate-aspartate (YVDD) or tyrosine-isoleucine-aspartate-aspartate (YIDD). Methods: Cloned wild-type and mutant HBV sequences were used as templates to test the sensitivity and specificity of the assay. A variety of primer construction, primer concentration, dNTP concentration, and annealing temperature of primers were systematically examined. Pair primers specific to rtL180M and rtM204V were selected for YVDD detection. Primer specific to rtM204I with an additional 3′-penultimate base mismatched to both the mutant and wild-type sequence was selected for YIDD detection. We applied this assay to study YMDD mutants in 28 chronic hepatitis B patients before and after lamivudine treatment. Results: We could detect as little as 0.001%-0.00001% of mutant viruses coexisting in 108-109 copies of wild-type HBV using this assay. YMDD mutants were detected in 8 of 12 HBeAg-positive patients and 8 of 16 HBeAg-negative patients before lamivudine treatment. After treatment, two more patients in HBeAg-positive patients and seven more patients in HBeAg-negative patients developed YMDD mutations. Conclusion: We developed a highly sensitive and specific assay for detecting YMDD mutants. This assay can be applied to monitor chronic hepatitis B patients before and during lamivudine treatment. ? 2006 The WJG Press. All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749371539&doi=10.3748%2fwjg.v12.i33.5301&partnerID=40&md5=fa2f631acb86c7c6da02b57c693550a6 https://scholars.lib.ntu.edu.tw/handle/123456789/557501 |
ISSN: | 1007-9327 | DOI: | 10.3748/wjg.v12.i33.5301 | SDG/關鍵字: | aspartic acid; hepatitis B(e) antigen; isoleucine; lamivudine; leucine; methionine; mutant protein; parathion; tyrosine; valine; 3' untranslated region; article; base mispairing; clinical article; concentration (parameters); controlled study; gene construct; genetic selection; hepatitis B; Hepatitis B virus; human; molecular cloning; mutational analysis; patient monitoring; polymerase chain reaction; protein motif; sensitivity and specificity; sequence analysis; temperature measurement; virus mutant; wild type |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。